Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28241746)

Published in BMC Infect Dis on February 27, 2017

Authors

Bingbing Qiao1, Jianzhen Wu2, Qiquan Wan3, Sheng Zhang4, Qifa Ye4,5

Author Affiliations

1: Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, People's Republic of China.
2: Department of Cadre Care, the Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, People's Republic of China.
3: Department of Transplant Surgery, the Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, People's Republic of China. 13548685542@163.com.
4: Department of Transplant Surgery, the Third Xiangya Hospital, Central South University, Changsha 410013, Hunan, People's Republic of China.
5: Department of Transplant Surgery, Zhongnan Hospital, Wuhan University, Wuhan 430071, Hubei, People's Republic of China.

Articles cited by this

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control (2008) 24.70

Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis (1988) 17.69

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Infection in solid-organ transplant recipients. N Engl J Med (2007) 5.47

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis (2007) 3.93

Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis (2008) 3.18

Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis (2010) 2.15

Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl (2015) 2.04

Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensity-adjusted study. Clin Infect Dis (2014) 1.98

Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl (2012) 1.90

Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS One (2012) 1.40

[138 episodes of bacteremia or fungemia in patients with solid organ (renal or hepatic) transplantation]. Med Clin (Barc) (1994) 1.39

Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl (2004) 1.22

Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection (2013) 1.17

Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med (2005) 1.17

Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis (2009) 1.15

Early catheter removal decreases incidence of urinary tract infections in renal transplant recipients. Transplant Proc (1998) 1.14

Early bacteremia after solid organ transplantation. Transplant Proc (2009) 1.12

Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl (2010) 1.10

Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control (1992) 1.10

Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis (2009) 1.05

Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology (1995) 1.05

Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J (2009) 1.04

Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant (2009) 1.03

Routine insertion of ureteral stent in live-donor renal transplantation: is it worthwhile? Urology (2005) 1.03

Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management. Liver Transpl (2011) 1.02

Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation (2010) 1.01

Mortality predictors of bloodstream infections in solid-organ transplant recipients. Exp Clin Transplant (2012) 0.99

Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis (1991) 0.99

Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl (2000) 0.94

Bloodstream infection after living donor liver transplantation. Scand J Infect Dis (2008) 0.94

Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. Eur J Clin Microbiol Infect Dis (2009) 0.93

Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles. Transplant Proc (2012) 0.91

Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl (2001) 0.89

Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant (2007) 0.89

Bacteremia and septic shock after solid-organ transplantation. Transplant Proc (2005) 0.88

Successful use of gentamycin as an antibiotic prophylaxis regimen to reduce the rate of healthcare-associated infections after renal transplantation. Braz J Infect Dis (2013) 0.86

Distribution and resistance of pathogens in liver transplant recipients with Acinetobacter baumannii infection. Ther Clin Risk Manag (2015) 0.83

Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients. Transpl Infect Dis (2012) 0.83

Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transplant (1997) 0.82

Autopsy-determined causes of death in solid organ transplant recipients. Transplant Proc (2004) 0.82

The epidemiology and distribution of pathogens and risk factors for mortality in liver transplant recipients with Gram negative bacteremia. Hepatogastroenterology (2014) 0.82

Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study. Transplant Proc (2014) 0.82

The risk factors for mortality in deceased donor liver transplant recipients with bloodstream infections. Transplant Proc (2013) 0.81

Epidemiology and risk factors for nosocomial bloodstream infections in solid organ transplants over a 10-year period. Transpl Infect Dis (2016) 0.81

Bloodstream infections during the first year after pediatric small bowel transplantation. Pediatr Infect Dis J (2012) 0.80

Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation (2000) 0.80

Comparative risk of bloodstream infection in organ transplant recipients. Infect Control Hosp Epidemiol (1994) 0.80

Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect (2014) 0.80

Bloodstream infections after solid-organ transplantation. Virulence (2016) 0.79

The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia. Hepatogastroenterology (2015) 0.78

Six-month incidence of bloodstream infections in intestinal transplant patients. Transpl Infect Dis (2011) 0.78

Bloodstream infections among solid organ transplant recipients: epidemiology, microbiology, associated risk factors for morbility and mortality. Transplant Rev (Orlando) (2014) 0.78

Factors influencing mortality in solid organ transplant recipients with bloodstream infection. Clin Microbiol Infect (2015) 0.78

Risk Factors for Bloodstream Infection After Living-donor Liver Transplantation in Children. Pediatr Infect Dis J (2015) 0.77

Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes. Transplant Proc (2014) 0.77

Analysis of bacteremia after pancreatic transplantation with enteric drainage. Transplant Proc (2008) 0.77

Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias. Eur J Clin Microbiol Infect Dis (2014) 0.77

Septicemia in renal transplant recipients: epidemiology and prognosis. Transplant Proc (1989) 0.76

Death and kidney allograft dysfunction after bacteremia. Clin Exp Nephrol (2015) 0.76

Etiologic agents of bacteremia in the early period after simultaneous pancreas-kidney transplantation. Transplant Proc (2009) 0.76

Outcome of bacteremia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae after solid organ transplantation. Transplant Proc (2014) 0.76

Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. Elife (2016) 0.76

Community-onset bacteremia in kidney transplant recipients: The recipients fare well in terms of mortality and kidney injury. J Microbiol Immunol Infect (2014) 0.76